Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill aims to fight advanced lymphoma when other treatments fail

NCT ID NCT06755450

Recruiting now Disease control Sponsor: Aurigene Discovery Technologies Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests an oral drug called AUR112 in 40 adults with relapsed advanced lymphoma. The main goals are to check safety, find the right dose, and see how the drug moves through the body. It is the first time this drug is being tested in humans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AUR112 (oral drug)
What this could lead to
If successful, this could point toward a new treatment option for patients with relapsed advanced lymphoma who have limited alternatives.
What could go wrong
This is a very early, first-in-human trial with only 40 participants. The drug may not be safe or effective, and side effects are unknown. Many early-stage drugs do not advance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia Hodgkins lymphoma non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED ADVANCED LYMPHOMAS

Contacts and locations

Locations

  • AIIMS, Bhubaneswar

    RECRUITING

    Bhubaneswar, Odisha, 751019, India

  • AIIMS, New Delhi

    ACTIVE_NOT_RECRUITING

    New Delhi, New Delhi, 110029, India

  • AIIMS, Rishikesh

    RECRUITING

    Rishikesh, Uttarakhand, 249203, India

  • Armed Forces Medical College

    NOT_YET_RECRUITING

    Pune, Maharashtra, 411040, India

  • HCG Cancer Centre

    RECRUITING

    Nagpur, Maharashtra, 440026, India

  • Health Care Global Enterprises

    ACTIVE_NOT_RECRUITING

    Bangalore, Karnataka, 560027, India

  • Jeevan Amrut Hematology Center, Aurangabad

    RECRUITING

    Aurangabad, Maharashtra, 431001, India

  • Max Super Specialty Hospital

    ACTIVE_NOT_RECRUITING

    Sāket, New Delhi, 110017, India

  • National Cancer Institute , All India Institute of Medical Sciences

    RECRUITING

    Jhajjar, Haryana, 124105, India

  • Novo Solitaire Care

    RECRUITING

    Pune, Maharashtra, 411014, India

  • Onco Life Cancer, Centre, Satara

    RECRUITING

    Satara, Maharashtra, 415519, India

  • Sahyadri Hospital Private Limited

    RECRUITING

    Pune, Maharashtra, 410014, India

  • Siddharth Gupta Memorial Hospital,

    RECRUITING

    Wardha, Maharashtra, 442107, India

  • Sir Sayajirao General Hospital (SSG)

    ACTIVE_NOT_RECRUITING

    Vadodara, Gujarat, 390001, India

  • Somani Hospital

    ACTIVE_NOT_RECRUITING

    Jaipur, Rajasthan, 302019, India

  • Srinivasam Cancer Care Multi Speciality Hospitals India Pvt Ltd. , Bangalore 560072.

    RECRUITING

    Bangalore, Karnataka, 560027, India

  • Sunact Cancer Institute Pvt. Ltd

    RECRUITING

    Thane, Maharashtra, 400 615, India

  • Tata Medical Centre

    ACTIVE_NOT_RECRUITING

    Kolkata, West Bengal, 700160, India

  • Tata Memorial Hospital

    RECRUITING

    Pārel, Mumbai, 400012, India

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.